LGT Financial Advisors’s Boston Scientific BSX Stock Holding History

LGT Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45	Closed	-$2.82K	–	228
2026 Q1	$2.82K	Sell	45 -71	-61%	-$5.68K	0.01%	226
2025 Q4	$11.1K	Hold	116	–	–	0.07%	128
2025 Q3	$11.3K	Hold	116	–	–	0.02%	222
2025 Q2	$12.5K	Buy	116 +62	+115%	+$6.27K	0.03%	191
2025 Q1	$5.45K	Sell	54 -462	-90%	-$46.5K	0.02%	218
2024 Q4	$46.1K	Hold	516	–	–	0.1%	159
2024 Q3	$43.2K	Sell	516 -745	-59%	-$58.7K	0.11%	145
2024 Q2	$97.1K	Sell	1,261 -1,918	-60%	-$140K	0.2%	86
2024 Q1	$218K	Sell	3,179 -139	-4%	-$8.94K	0.25%	88
2023 Q4	$192K	Buy	3,318 +49	+1%	+$2.62K	0.23%	100
2023 Q3	$173K	Buy	+3,269	New	+$171K	0.22%	98

Other funds holding BSX

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

LGT Financial Advisors's BSX Position: Q2 2026 in Review

LGT Financial Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 45 shares — an estimated $2.82K sold.

LGT Financial Advisors first reported a position in BSX in Q3 2023 and held it in 11 quarters. The position peaked at $218K in Q1 2024. 569 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

LGT Financial Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
LGT Financial Advisors sold 45 Boston Scientific shares in Q2 2026, an estimated $2.82K.
LGT Financial Advisors first reported a position in Boston Scientific in Q3 2023 and held it in 11 quarters.
LGT Financial Advisors's Boston Scientific position peaked at $218K in Q1 2024.
569 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on LGT Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.